How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation

Table 1 Characteristics of the study patients

	Total	HIT-	HIT+	Among HIT+
	Total	HIT-	HIT+	HITT-	HITT+
N	111	92	19	9	10
Age (median)	69	69	69	74	60
Sex-ratio (M/F)	60/51	49/43	11/8	5/4	6/4
Nadir platelet count 10⁹/L (median)	70	70	55	52	81
Prothrombin Time ratio (median)	1.27	1.27	1.27	1.44	1.09
Fibrinogen level g/L	4.6	4.4	5.0	5.1	5.0
Intensive Care Unit %	48	45	63	67	60
4T score (median)	4	4	6	5	6

HIT -: patients in whom HIT diagnosis was ruled out
HIT+: patients with HIT diagnosis, with thrombotic complications (HITT+), without thrombotic complications (HITT-)

ISSN: 1477-9560